Cargando…

Intrachromosomal Amplification, Locus Deletion and Point Mutation in the Aquaglyceroporin AQP1 Gene in Antimony Resistant Leishmania (Viannia) guyanensis

BACKGROUND: Antimony resistance complicates the treatment of infections caused by the parasite Leishmania. METHODOLOGY/PRINCIPAL FINDINGS: Using next generation sequencing, we sequenced the genome of four independent Leishmania guyanensis antimony-resistant (SbR) mutants and found different chromoso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monte-Neto, Rubens, Laffitte, Marie-Claude N., Leprohon, Philippe, Reis, Priscila, Frézard, Frédéric, Ouellette, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332685/ https://www.ncbi.nlm.nih.gov/pubmed/25679388 http://dx.doi.org/10.1371/journal.pntd.0003476

Ejemplares similares

Leishmania (Viannia) guyanensis Infection, Austria
por: Poeppl, Wolfgang, et al.
Publicado: (2012)

Mucosal Leishmaniasis Caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon
por: Guerra, Jorge Augusto de Oliveira, et al.
Publicado: (2011)

First Report of Canine Infection by Leishmania (Viannia) guyanensis in the Brazilian Amazon
por: Santos, Francisco J. A., et al.
Publicado: (2020)

Insights from Leishmania (Viannia) guyanensis in vitro behavior and intercellular communication
por: Pereira, Luiza O. R., et al.
Publicado: (2021)

Leishmania (Viannia) guyanensis Causing Localized Cutaneous Leishmaniasis in a Traveler
por: Motie, Ian K, et al.
Publicado: (2022)

Antimony resistance in Leishmania (Viannia) braziliensis clinical isolates from atypical lesions associates with increased ARM56/ARM58 transcripts and reduced drug uptake
por: Rugani, Jeronimo Nunes, et al.
Publicado: (2019)

Biophysical and Pharmacological Characterization of Energy-Dependent Efflux of Sb in Laboratory-Selected Resistant Strains of Leishmania (Viannia) Subgenus
por: dos Reis, Priscila G., et al.
Publicado: (2017)

Leishmania naiffi and Leishmania guyanensis reference genomes highlight genome structure and gene evolution in the Viannia subgenus
por: Coughlan, Simone, et al.
Publicado: (2018)

Gene Expression Profiling and Molecular Characterization of Antimony Resistance in Leishmania amazonensis
por: do Monte-Neto, Rubens L., et al.
Publicado: (2011)

Molecular characterization of the MRPA transporter and antimony uptake in four New World Leishmania spp. susceptible and resistant to antimony()
por: Moreira, Douglas S., et al.
Publicado: (2013)

Distinct Macrophage Fates after in vitro Infection with Different Species of Leishmania: Induction of Apoptosis by Leishmania (Leishmania) amazonensis, but Not by Leishmania (Viannia) guyanensis
por: DaMata, Jarina Pena, et al.
Publicado: (2015)

Sequencing of hsp70 for discernment of species from the Leishmania (Viannia) guyanensis complex from endemic areas in Colombia
por: Hoyos, Juliana, et al.
Publicado: (2022)

Phenotypic characterization of Leishmania spp. causing cutaneous leishmaniasis in the lower Amazon region, western Pará state, Brazil, reveals a putative hybrid parasite, Leishmania (Viannia) guyanensis × Leishmania (Viannia) shawi shawi
por: Jennings, Yara Lins, et al.
Publicado: (2014)

Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant Leishmania infantum
por: Leprohon, Philippe, et al.
Publicado: (2009)

Draft Genome Sequence of French Guiana Leishmania (Viannia) guyanensis Strain 204-365, Assembled Using Long Reads
por: Batra, Dhwani, et al.
Publicado: (2018)

MRPA-independent mechanisms of antimony resistance in Leishmania infantum
por: Douanne, Noélie, et al.
Publicado: (2020)

Immuno-pharmacokinetics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis Caused by Leishmania (Viannia)
por: Gómez, María Adelaida, et al.
Publicado: (2020)

Resistance of Leishmania (Viannia) Panamensis to Meglumine Antimoniate or Miltefosine Modulates Neutrophil Effector Functions
por: Regli, Ivo B., et al.
Publicado: (2018)

Serine proteases profiles of Leishmania (Viannia) braziliensis clinical isolates with distinct susceptibilities to antimony
por: Zabala-Peñafiel, Anabel, et al.
Publicado: (2021)

Proteomic and Genomic Analyses of Antimony Resistant Leishmania infantum Mutant
por: Brotherton, Marie-Christine, et al.
Publicado: (2013)

Molecular tools confirm natural Leishmania (Viannia) guyanensis/L. (V.) shawi hybrids causing cutaneous leishmaniasis in the Amazon region of Brazil
por: Lima, Ana Carolina S., et al.
Publicado: (2021)

Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-α production
por: Souza, Anselmo S, et al.
Publicado: (2010)

Miltefosine and Antimonial Drug Susceptibility of Leishmania Viannia Species and Populations in Regions of High Transmission in Colombia
por: Fernández, Olga Lucía, et al.
Publicado: (2014)

Intercalated low doses of antimonials for disseminated cutaneous leishmaniasis caused by Leishmania guyanensis: A successful approach in Amazonas, Brazil
por: Monçale Campos, Aline Grasielli, et al.
Publicado: (2018)

Comparative genomic analysis of Leishmania (Viannia) peruviana and Leishmania (Viannia) braziliensis
por: Valdivia, Hugo O., et al.
Publicado: (2015)

Identification and Biological Characterization of Leishmania (Viannia) guyanensis Isolated from a Patient with Tegumentary Leishmaniasis in Goiás, a Nonendemic Area for This Species in Brazil
por: Pires, Alause da Silva, et al.
Publicado: (2015)

Filling the gaps in Leishmania naiffi and Leishmania guyanensis genome plasticity
por: Patiño, Luz H, et al.
Publicado: (2021)

Correction: Miltefosine and Antimonial Drug Susceptibility of Leishmania Viannia Species and Populations in Regions of High Transmission in Colombia
Publicado: (2014)

Drug resistance analysis by next generation sequencing in Leishmania
por: Leprohon, Philippe, et al.
Publicado: (2014)

Instability of aquaglyceroporin (AQP) 2 contributes to drug resistance in Trypanosoma brucei
por: Quintana, Juan F., et al.
Publicado: (2020)

Aquaglyceroporin AQP7's affinity for its substrate glycerol. Have we reached convergence in the computed values of glycerol-aquaglyceroporin affinity?
por: Falato, Michael, et al.
Publicado: (2022)

Molecular Characterization of Aquaglyceroporine: A Novel Mutation in LmAQP1 from Leishmania major (MRHO/IR/75/ER)
por: ESLAMI, Gilda, et al.
Publicado: (2019)

Plasticity of the Leishmania genome leading to gene copy number variations and drug resistance
por: Laffitte, Marie-Claude N., et al.
Publicado: (2016)

Species-Specific Antimonial Sensitivity in Leishmania Is Driven by Post-Transcriptional Regulation of AQP1
por: Mandal, Goutam, et al.
Publicado: (2015)

Leishmania (Viannia) naiffi: rare enough to be neglected?
por: Fagundes-Silva, Giselle Aparecida, et al.
Publicado: (2015)

Mutilating localized cutaneous leishmaniasis caused by Leishmania guyanensis()
por: Silva, Dina Fabrício da, et al.
Publicado: (2023)

Crystal structure of the aquaglyceroporin PfAQP from the malarial parasite Plasmodium falciparum
por: Newby, Zachary E R, et al.
Publicado: (2008)

Targeted deletion of the aquaglyceroporin AQP9 is protective in a mouse model of Parkinson’s disease
por: Stahl, Katja, et al.
Publicado: (2018)

Aquaglyceroporin PbAQP is required for efficient progression through the liver stage of Plasmodium infection
por: Promeneur, Dominique, et al.
Publicado: (2018)

Comparative Assessment of DNA Targets and Amplification Methods for Leishmania (Viannia) Detection in Human Samples
por: Rosales-Chilama, Mariana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bm6s4qduvm5p3f0ducevem1i9f